Literature DB >> 18478321

Does the use of nicotine replacement therapy during pregnancy affect pregnancy outcomes?

Kimberly H Gaither1, Larissa R Brunner Huber, Michael E Thompson, Yvette M Huet-Hudson.   

Abstract

OBJECTIVES: Although nicotine replacement therapies (NRT) may assist with smoking cessation, little is known about the safety of NRT use during pregnancy. Our purpose was two-fold: to determine characteristics of women prescribed or recommended NRT during pregnancy and to investigate whether NRT prescription/recommendation was associated with adverse pregnancy outcomes using data from the 2004 Pregnancy Risk Assessment Monitoring System.
METHODS: Smoking and NRT referral was self-reported by 5,716 women. Information on pregnancy outcomes was obtained from birth certificates. Multivariate logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: Smokers <35 years of age and of Hispanic, Non-Hispanic Black, and Asian/Pacific Islander race/ethnicity were less likely to be prescribed or recommended NRT during pregnancy. After adjustment for age, marital status, education, and race/ethnicity, women recommended NRT had twice the risk of low birthweight as compared to nonsmokers (OR = 1.95, 95% CI: 1.10, 3.46) while smokers had 1.31 times the risk of low birthweight (95% CI: 0.92, 1.87). Results for preterm birth were similar after adjustment for the same confounding variables (NRT: OR = 2.04, 95% CI: 1.14, 3.63 and smoking: OR = 1.09, 95% CI: 0.74, 1.61).
CONCLUSIONS: Risks of low birthweight and preterm birth were highest for women prescribed or recommended NRT. These findings may be related to frequency of maternal smoking. While heavier smokers may be more likely to be recommended NRT, they also may have the most difficulty with cessation. Greater efforts should be made to ensure that these women do successfully cease smoking.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18478321     DOI: 10.1007/s10995-008-0361-1

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  20 in total

1.  Nicotine replacement therapy in pregnancy.

Authors:  Tim Coleman; John Britton; Jim Thornton
Journal:  BMJ       Date:  2004-04-24

Review 2.  Nicotine replacement therapy during pregnancy.

Authors:  N L Benowitz
Journal:  JAMA       Date:  1991-12-11       Impact factor: 56.272

3.  Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics.

Authors:  C A Oncken; H Hardardottir; D K Hatsukami; V R Lupo; J F Rodis; J S Smeltzer
Journal:  Obstet Gynecol       Date:  1997-10       Impact factor: 7.661

4.  The accuracy of self-report of smoking status in pregnant women.

Authors:  R A Walsh; S Redman; L Adamson
Journal:  Addict Behav       Date:  1996 Sep-Oct       Impact factor: 3.913

5.  Nicotine replacement prescription practices of obstetric and pediatric clinicians.

Authors:  C A Oncken; L Pbert; J K Ockene; J Zapka; A Stoddard
Journal:  Obstet Gynecol       Date:  2000-08       Impact factor: 7.661

6.  Exposure to tobacco smoke in utero and the risk of stillbirth and death in the first year of life.

Authors:  K Wisborg; U Kesmodel; T B Henriksen; S F Olsen; N J Secher
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

7.  Accelerated metabolism of nicotine and cotinine in pregnant smokers.

Authors:  Delia Dempsey; Peyton Jacob; Neal L Benowitz
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

8.  Smoking during pregnancy--United States, 1990-2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-10-08       Impact factor: 17.586

9.  Influence of nicotine chewing gum on fetal blood flow.

Authors:  A Lindblad; K Marsál
Journal:  J Perinat Med       Date:  1987       Impact factor: 1.901

10.  Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers.

Authors:  W Luck; H Nau; R Hansen; R Steldinger
Journal:  Dev Pharmacol Ther       Date:  1985
View more
  19 in total

1.  The use of central nervous system active drugs during pregnancy.

Authors:  Bengt Källén; Natalia Borg; Margareta Reis
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-10

Review 2.  The brain-placental axis: Therapeutic and pharmacological relevancy to pregnancy.

Authors:  Susanta K Behura; Pramod Dhakal; Andrew M Kelleher; Ahmed Balboula; Amanda Patterson; Thomas E Spencer
Journal:  Pharmacol Res       Date:  2019-10-07       Impact factor: 7.658

3.  The long-term effects of prenatal nicotine exposure on neurologic development.

Authors:  Jane Blood-Siegfried; Elizabeth K Rende
Journal:  J Midwifery Womens Health       Date:  2010 Mar-Apr       Impact factor: 2.388

4.  A randomized clinical trial of trans-dermal nicotine replacement in pregnant African-American smokers.

Authors:  Ayman A E El-Mohandes; Richard Windsor; Sylvia Tan; David C Perry; Marie G Gantz; Michele Kiely
Journal:  Matern Child Health J       Date:  2013-07

Review 5.  Long-term consequences of fetal and neonatal nicotine exposure: a critical review.

Authors:  Jennifer E Bruin; Hertzel C Gerstein; Alison C Holloway
Journal:  Toxicol Sci       Date:  2010-04-02       Impact factor: 4.849

Review 6.  Prenatal exposure to drugs: effects on brain development and implications for policy and education.

Authors:  Barbara L Thompson; Pat Levitt; Gregg D Stanwood
Journal:  Nat Rev Neurosci       Date:  2009-03-11       Impact factor: 34.870

7.  Early Life Exposure to Nicotine: Postnatal Metabolic, Neurobehavioral and Respiratory Outcomes and the Development of Childhood Cancers.

Authors:  Laiba Jamshed; Genevieve A Perono; Shanza Jamshed; Alison C Holloway
Journal:  Toxicol Sci       Date:  2020-11-01       Impact factor: 4.849

8.  Major depression and PTSD in pregnant smokers enrolled in nicotine gum treatment trial.

Authors:  Ellen Dornelas; Cheryl Oncken; John Greene; Heather Z Sankey; Henry R Kranzler
Journal:  Am J Addict       Date:  2013-01

9.  Timing of prenatal smoking cessation or reduction and infant birth weight: evidence from the United Kingdom Millennium Cohort Study.

Authors:  Ji Yan; Peter A Groothuis
Journal:  Matern Child Health J       Date:  2015-03

10.  Differential responses of hippocampal neurons and astrocytes to nicotine and hypoxia in the fetal guinea pig.

Authors:  Tamara Blutstein; Michael A Castello; Shaun S Viechweg; Maria M Hadjimarkou; Joseph A McQuail; Mary Holder; Loren P Thompson; Jessica A Mong
Journal:  Neurotox Res       Date:  2012-11-29       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.